112 related articles for article (PubMed ID: 987891)
1. Contraception with d-norgestrel silastic rods. Plasma levels of d-norgestrel and influence on the ovarian function.
Weiner E; Johansson ED
Contraception; 1976 Nov; 14(5):551-62. PubMed ID: 987891
[No Abstract] [Full Text] [Related]
2. Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles.
Victor A; Johansson ED
Contraception; 1976 Aug; 14(2):215-26. PubMed ID: 949897
[No Abstract] [Full Text] [Related]
3. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
4. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function.
Lähteenmäki P
Acta Obstet Gynecol Scand Suppl; 1978; 76():1-43. PubMed ID: 696249
[No Abstract] [Full Text] [Related]
5. Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel.
Weiner E; Johansson ED
Contraception; 1976 Jul; 14(1):81-92. PubMed ID: 975814
[No Abstract] [Full Text] [Related]
6. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
Moore DE; Roy S; Stanczyk FZ; Mishell DR
Contraception; 1978 Apr; 17(4):315-28. PubMed ID: 648154
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of d-norgestrel after oral administration.
Weiner E; Victor A; Johansson ED
Contraception; 1976 Nov; 14(5):563-70. PubMed ID: 987892
[No Abstract] [Full Text] [Related]
8. Mode of action of DL-norgestrel and ethinylestradiol combination in postcoital contraception.
Ling WY; Robichaud A; Zayid I; Wrixon W; MacLeod SC
Fertil Steril; 1979 Sep; 32(3):297-302. PubMed ID: 488410
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
Ling WY; Wrixon W; Acorn T; Wilson E; Collins J
Fertil Steril; 1983 Nov; 40(5):631-6. PubMed ID: 6628707
[TBL] [Abstract][Full Text] [Related]
10. Effect of norgestrel administered intermittently on pituitary ovarian function.
Craft I; Foss GL; Warren RJ; Fotherby K
Contraception; 1975 Nov; 12(5):589-98. PubMed ID: 1192745
[No Abstract] [Full Text] [Related]
11. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U
Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
[TBL] [Abstract][Full Text] [Related]
12. Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review.
Korba VD; Heil CG
Fertil Steril; 1975 Oct; 26(10):973-81. PubMed ID: 1183625
[TBL] [Abstract][Full Text] [Related]
13. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
Ling WY; Wrixon W; Zayid I; Acorn T; Popat R; Wilson E
Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on the SH 1000 as oral contraception (author's transl)].
Takayanagi M; Kamada M; Kushiki N; Lyo K; Fujiwara M
Nihon Funin Gakkai Zasshi; 1974 Oct; 19(4):36-45. PubMed ID: 4478828
[No Abstract] [Full Text] [Related]
15. A D-norgestrel-releasing IUD.
Nilsson CG; Johansson ED; Luukkainen T
Contraception; 1976 Apr; 13(4):503-14. PubMed ID: 1253602
[No Abstract] [Full Text] [Related]
16. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
Miller JF; Fotherby K; Bye PG; Elstein M
Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191
[TBL] [Abstract][Full Text] [Related]
17. Progestagen-dependent effect on some plasma proteins during oral contraception.
Liukko P; Erkkola R; Bergink EW
Gynecol Obstet Invest; 1988; 25(2):118-22. PubMed ID: 2967233
[TBL] [Abstract][Full Text] [Related]
18. Relation between sex hormone binding globulin and D-norgestrel levels in plasma.
Victor A; Weiner E; Johansson ED
Acta Endocrinol (Copenh); 1977 Oct; 86(2):430-6. PubMed ID: 578629
[TBL] [Abstract][Full Text] [Related]
19. Elevation of serum prolactin during application of oral contraceptives.
Dericks-Tan JS; Taubert HD
Contraception; 1976 Jul; 14(1):1-8. PubMed ID: 975808
[No Abstract] [Full Text] [Related]
20. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
